研究業績
研究業績2017年度 英文原著
１．英文原著
1. Nakahara K, Nakane S, Nakajima M, Yamashita S, Mori T, Ando Y:
Effect of thymectomy for thymic atrophy in myasthenia gravis: A retrospective study on 93 patients.
J Neuroimmunol, 305: 182-185, 2017
2. Ishizaki M, Kedoin C, Ueyama H, Maeda Y, Yamashita S, Ando Y:
Utility of skinfold thickness measurement in non-ambulatory patients with Duchenne muscular dystrophy.
Neuromuscul Disord, 27: 24-28, 2017
3. Yamamoto F, Yamashita S, Kawano H, Tanigawa T, Mihara Y, Gonoi T, Ando Y:
Meningitis and ventriculitis due to Nocardia araoensis infection.
Intern Med, 56: 853-859, 2017
4. Tawara N, Yamashita S, Zhang X, Korogi M, Zhang Z, Doki T, Matsuo Y, Nakane S, Maeda Y, Sugie K, Suzuki N, Aoki M, Ando Y:
Pathomechanisms of anti-cN1A autoantibodies in sporadic inclusion body myositis.
Ann Neurol, 81: 512-525, 2017
5. Ikenoshita S, Yamashita S, Sakamoto T, Misumi Y, Ando Y:
Hemi-atrophy of tongue with contralateral hemiparesis in a patient with MADSAM.
J Clin Neurol, 13: 422-423, 2017
6. Yamashita S, Tawara N, Ando Y:
Anti-NT5C1A autoantibodies for the diagnosis and study of the pathogenesis of sporadic inclusion body myositis.
Clin Exp Neuroimmunol, 8: 292-301, 2017
7. Nagao Y, Nakajima M, Hirahara T, Wada K, Terasaki T, Nagamine M, Ando Y:
Calcified cerebral embolism due to a calcified amorphous tumor.
J Stroke Cerebrovasc Dis, 27: e115-e116, 2018
8. Yamashita S, Nakama T, Ueda M, Honda S, Kimura E, Konagaya M, Ando Y:
Tongue strength in patients with subacute myelo-optico-neuropathy.
J Clin Neurosci, 47: 84-88, 2018
9. Inoue Y, Ueda M, Tasaki M, Takeshima A, Nagatoshi A, Masuda T, Misumi Y, Kosaka T, Nomura T, Mizukami M, Matsumoto S, Yamashita T, Takahashi H, Kakita A, Ando Y:
Sushi repeat-containing protein 1: a novel disease-associated molecule in cerebral amyloid angiopathy.
Acta Neuropathol, 134: 605-617, 2017
10. Inoue Y, Miyashita F, Koga M, Minematsu K, Toyoda K:
Unclear-onset intracerebral hemorrhage: Clinical characteristics, hematoma features, and outcomes.
Int J stroke, 12: 961-968, 2017
11. Inoue Y, Miyashita F, Minematsu K, Toyoda K:
Clinical characteristics and outcomes of intracerebral hemorrhage in very elderly.
J Stroke Cerebrovasc Dis, 27: 97-102, 2018
12. Ikeda T, Masuda T, Ueda M, Yamashita T, Misumi Y, Shinriki S, Ando Y:
Unwanted road to anemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.
Ann Clin Biochem, 55: 571-575, 2018
13. Yamashita T, Ueda M, Misumi Y, Masuda T, Nomura T, Tasaki M, Takamatsu K, Sasada K, Obayashi K, Matsui H, Ando Y:
Genetic and clinical characteristics of hereditary transthyretin amyloidosis in endemic and non-endemic areas: experience from a single-referral center in Japan.
J Neurol, 265: 134-140, 2018
14. Okada M, Misumi Y, Ueda M, Yamashita T, Masuda T, Tasaki M, Ando Y:
A novel transthyretin variant V28S (p.V48S) with a double-nucleotide substitution in the same codon.
Amyloid, 24: 231-232, 2017
15. Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y:
Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
Neurology, 88: 2192-2197, 2017
16. Suenaga G, Ikeda T, Masuda T, Motokawa H, Yamashita T, Takamatsu K, Misumi Y, Ueda M, Matsui H, Senju S, Ando Y:
Inflammatory state exists in familial amyloid polyneuropathy that may be triggered by mutated transthyretin.
Sci Rep, 7: 1579, 2017
17. Matsumoto S, Ueda M, Yamashita T, Amano T, Misumi Y, Tasaki M, Masuda T, Mizukami M, Furuya H, Ando Y:
A late-onset case of hereditary transthyretin amyloidosis with a novel compound heterozygous mutation.
Amyloid, 24: 97-98, 2017
18. Tasaki M, Ueda M, Obayashi K, Kinoshita Y, Matsumoto S, Mizukami M, Masuda T, Misumi Y, Yamashita T, Ando Y:
Identification of amyloid precursor protein from autopsy and biopsy specimens using LMD-LC-MS/MS: the experience at Kumamoto University.
Amyloid, 24: 167-168, 2017
19. Izaki A, Obayashi K, Suenaga G, Ueda M, Yamashita T, Tasaki M, Yanagisawa Y, Masuda T, Misumi Y, Ando Y:
In vitro and in vivo assessment of novel derivatives for detecting various amyloid deposits.
Amyloid, 24: 17, 2017
20. Nomura T, Yamashita T, Misumi Y, Ueda M, Masuda T, Tasaki M, Ando Y:
A case with a novel variant transthyretin A36D presenting cardiac phenotype.
Amyloid, 24: 100, 2017
21. Tsuda Y, Misumi Y, Ueda M, Tasaki M, Huang G, Masuda T, Suenaga G, Kinoshita Y, Obayashi K, Yamashita T, Ando Y:
Iatrogenic systemic transthyretin amyloid deposits in a case with domino liver transplantation: an autopsy case study.
Amyloid, 24: 125, 2017
22. Obayashi K, Ueda M, Yamashita T, Tasaki M, Izaki A, Yanagisawa Y, Masuda T, Misumi Y, Ando Y:
Long-term effects of liver transplantation on small-fiber dysfunction in Japanese transthyretin (ATTR) V30M hereditary amyloidosis with polyneuropathy (FAP).
Amyloid, 24: 99, 2017
23. Watanabe T, Obayashi K, Misumi Y, Tasaki M, Shinriki S, Ando T, Akagami T, Ueda M, Yamashita T, Hirotani S, Ando Y:
Hereditary transthyretin amyloidosis associated with a transthyretin variant Thr59Arg.
Amyloid, 24: 119, 2017
24. Koike H, Ikeda S, Takahashi M, Kawagashira Y, Iijima M, Misumi Y, Ando Y, Ikeda SI, Katsuno M, Sobue G:
Disruption of blood-nerve barriers in hereditary transthyretin (ATTR) amyloidosis.
Amyloid, 24: 89-90, 2017
25. Mizukami M, Ueda M, Tasaki M, Misumi Y, Masuda T, Matsumoto S, Yamashita T, Ando Y:
Clinicopathological and biochemical findings of late-onset hereditary transthyretin amyloidosis 16 years after liver transplantation: an autopsy case study.
Amyloid, 24: 122, 2017
26. Misumi Y, Oshima T, Ueda M, Yamashita T, Tasaki M, Masuda T, Obayashi K, Ando Y:
Occurrence factors and clinical picture of iatrogenic transthyretin amyloidosis after domino liver transplantation.
Amyloid, 24: 123-124, 2017
27. Yanagisawa Y, Obayashi K, Tasaki M, Izaki A, Masuda T, Misumi Y, Ueda M, Yamashita T, Ando Y:
Clinicopathological characteristics of a patient with ureteral amyloidosis.
Amyloid, 24: 101, 2017
28. Yamashita T, Ueda M, Tasaki M, Masuda T, Misumi Y, Takamatsu K, Obayashi K, Ando Y:
Establishment of a diagnostic center for amyloidosis in Japan by Kumamoto University.
Amyloid, 24: 169-170, 2017
29. Misumi Y, Ueda M, Yamashita T, Masuda T, Kinoshita Y, Tasaki M, Nagase T, Ando Y:
Novel screening for transthyretin amyloidosis by using fat ultrasonography.
Ann Neurol, 81: 604-608, 2017
30. Huang G, Ueda M, Tasaki M, Yamashita T, Misumi Y, Masuda T, Suenaga G, Inoue Y, Kinoshita Y, Matsumoto S, Mizukami M, Tsuda Y, Nomura T, Obayashi K, Ando Y:
Clinicopathological and biochemical findings of thyroid amyloid in hereditary transthyretin amyloidosis with and without liver transplantation.
Amyloid, 24: 24-29, 2017
31. Oda S, Utsunomiya D, Nakaura T, Yuki H, Kidoh M, Morita K, Takashio D, Yamamuro M, Izumiya Y, Hirakawa K, Ishida T, Tsujita K, Ueda M, Yamashita T, Ando Y, Hata H, Yamashita Y:
Identification and assessment of cardiac amyloidosis by myocardial strain analysis of cardiac magnetic resonance imaging.
Circ J, 81: 1014-1021, 2017
32. Oda S, Utsunomiya D, Nakaura T, Morita K, Komi M, Yuki H, Kidoh M, Hirata K, Funama Y, Yamamuro M, Ogawa H, Ueda M, Yamashita T, Ando Y, Yamashita Y:
Cardiovascular magnetic resonance myocardial T1 mapping to detect and quantify cardiac involvement in familial amyloid polyneuropathy.
Eur Radiol, 27: 4631-4638, 2017
33. Nagatoshi A, Ueda M, Ueda A, Tasaki M, Inoue Y, Ma M, Masuda T, Mizukami M, Matsumoto S, Kosaka T, Kawano T, Ito T, Ando Y:
Serum amyloid P component: a novel potential player in vessel degeneration in CADASIL.
J Neurol Sci, 379: 69-76, 2017
34. Nishi S, Hoshino J, Yamamoto S, Fuji H, Goto S, Ubara Y, Motomiya Y, Morita H, Takaichi K, Yamagata K, Shigematsu T, Ueda M, Ando Y:
A multicenter cross sectional study for dialysis related amyloidosis in Japan.
Nephrology, 23: 640-645, 2018
35. Takashio S, Yamamuro M, Izumiya Y, Hirakawa K, Marume K, Yamamoto M, Ueda M, Yamashita T, Ishibashi-Ueda H, Yasuda S, Ogawa H, Ando Y, Anzai T, Tsujita K:
Diagnostic utility of cardiac troponin T level in patients with cardiac amyloidosis.
ESC Heart Fail, 5: 27-35, 2018
36. Shimazaki C, Hata H, Iida S, Ueda M, Katoh N, Sekishima Y, Ikeda S, Yazaki M, Fukushima W, Ando Y:
Nationwide Survey of 741 Patients with Systemic Amyloid Light-chain Amyloidosis in Japan.
Intern Med, 57: 181-187, 2018
37. Sekijima, Y, Yazaki M, Ueda M, Koike H, Yamada M, Ando Y:
First Nationwide Survey on Wild-type ATTR Amyloidosis in Japan.
Amyloid, 25: 8-10, 2017
38. Shinriki S, Jono H, Maeshiro M, Nakamura T, Guo J, Li JD, Ueda M, Yoshida R, Shinohara M, Nakayama H, Matsui H, Ando Y:
Loss of CYLD promotes cell invasion via ALK5 stabilization in oral squamous cell carcinoma.
J Pathol, 244: 367-379, 2018
39. Masuda T, Ueda M, Suenaga G, Misumi Y, Tasaki M, Izaki A, Yanagisawa Y, Inoue Y, Motokawa H, Matsumoto S, Mizukami M, Arimura A, Deguchi T, Nishio Y, Yamashita T, Inomata Y, Obayashi K, Ando Y:
Early skin denervation in hereditary and iatrogenic transthyretin amyloid neuropathy.
Neurology, 88: 2192-2197, 2017
40. Watari M, Nakane S, Mukaino A, Nakajima M, Mori Y, Maeda Y, Masuda T, Takamatsu K, Kouzaki Y, Higuchi O, Matsuo H, Ando Y:
Autoimmune postural orthostatic tachycardia syndrome.
Ann Clin Transl Neurol, 5: 486-492, 2018
41. Nakane S, Ando Y, Matsuo H:
Yips preceding baseball-related dystonia.
Parkinsonism Relat Disord, 50: 128-129, 2018
42. Ichinose K, Ohyama K, Furukawa K, Higuchi O, Mukaino A, Satoh K, Nakane S, Shimizu T, Umeda M, Fukui S, Nishino A, Nakajima H, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yoshida M, Kuroda N, Kawakami A:
Novel anti-suprabasin antibodies may contribute to the pathogenesis of neuropsychiatric systemic lupus erythematosus.
Clin Immunol, 193: 123-130, 2018
43. Nakae Y, Hyuga M, Kishimoto W, Fukunaga A, Tabata S, Maesako Y, Arima N, Terada Y, Komatsu K, Higuchi O, Nakane S, Arima T:
Multiple myeloma presenting with autoimmune autonomic ganglionathy.
Intern Med, 56: 3347-3351, 2017
44. Ishikawa H, Taniguchi A, Ii Y, Higuchi O, Matsuo H, Nakane S, Asahi M, Niwa A, Tomimoto H:
Double-seropositive myasthenia gravis with acetylcholine receptor and low-density lipoprotein receptor-related protein 4 antibodies associated with invasive lymphoma.
Neuromuscul Disord, 27: 914-917, 2017
45. Nakane S, Furutani K, Harada M, Urushihara R, Matsui N, Izumi Y, Kaji R:
Multimodal analysis based on high-field magnetic resonance and motor evoked potentials.
Clin Exp Neuroimmunol, 8: 43-46, 2017
46. Yoshifuku A, Yoneda K, Sakiyama Y, Higuchi O, Nakane S, Kanekura T:
Case of autoimmune autonomic ganglionopathy manifesting anhidrosis.
J Dermatol, 44: 1160-1163, 2017
47. Morimoto N, Takahashi S, Inaba T, Takamiya M, Kageyama Y, Morimoto M, Takahashi Y, Nishimura H, Nakane S, Abe K:
A case of seropositive autoimmune autonomic ganglionopathy with diffuse esophageal spasm.
J Clin Neurosci, 39: 90-92, 2017
48. Sakai W, Nakane S, Urasaki E, Nagaishi A, Toyoda K, Sadakata E, Fukudome T, Yamakawa Y, Matsuo H:
The cross-sectional area of paraspinal muscles predicts the efficacy of deep brain stimulation for camptocormia.
J Parkinsons Dis, 7: 247-253, 2017
49. Nakane S, Mukaino A, Maeda Y, Higuchi O, Matsuo H, Ando Y:
Extra-autonomic manifestations in autoimmune autonomic ganglionopathy: a Japanese survey.
J Neurol Neurosurg Psychiatry, 88: 367-368, 2017
50. Naganuma M, Inatomi Y, Nakajima M, Takeshi Ohta, Yonehara T, Ando Y:
Is the occlusion site of the lenticulostriate artery identified on admission related to clinical prognosis in patients with lacunar stroke?
J Stroke Cerebrovasc Dis, 27: 2035-2042, 2018
51. Naganuma M, Inatomi Y, Nakajima M, Yonehara T, Ando Y:
The association between uric acid level and 3-month functional outcome in acute ischemic stroke patients treated with/without edaravone.
Cerebrovasc Dis, 45: 115-123, 2018
52. Miura M, Nakajima M, Fujimoto A, Shiraishi S, Liebeskind DS, Ando Y:
Decreased signal intensity ratio on MRA reflects misery perfusion on SPECT in patients with intracranial stenosis.
J Neuroimaging, 28: 206-211, 2018
53. Miura M, Nakajima M, Fujimoto A, Kaku Y, Kawano T, Watanabe M, Kuratsu J, Ando Y:
High prevalence of small vessel disease long after cranial irradiation.
J Clin Neurosci, 46: 129-135, 2017
54. Tsukamoto H, Fujieda K, Senju S, Ikeda T, Oshiumi H, Nishimura Y:
Immune-suppressive effects of interleukin-6 on T-cell-mediated anti-tumor immunity.
Cancer Sci Mar, 109: 523-530, 2018
55. Ikeda T:
Stratified analyses are necessary to verify the influence of salt intake in MS.
Ann Neurol, 82: 648-649, 2017
56. Maeda Y, Yonemochi Y, Nakajyo Y, Hidaka H, Ikeda T, Ando Y:
CXCL12 and osteopontin from bone marrow-derived mesenchymal stromal cells improve muscle regeneration.
Sci Rep, 7: 3305, 2017
57. Nishi S, Muso E, Shimizu A, Sugiyama H, Yokoyama H, Ando Y, Goto S, Fujii H:
A clinical evaluation of renal amyloidosis in the Japan renal biopsy registry: a cross-sectional study.
Clin Exp Nephrol, 21: 624-632, 2017
58. Kasagi T, Nobata H, Suzuki K, Miura N, Banno S, Takami A, Yamashita T, Ando Y, Imai H:
Light chain deposition disease diagnosed with laser micro-dissection, liquid chromatography, and tandem mass spectrometry of nodular glomerular lesions.
Intern Med, 56: 61-66, 2017
59. Inatomi Y, Nakajima M, Yonehara T, Ando Y:
Ipsilateral tremor-like grasp reaction in a patient with ischemic stroke.
Cogn Behav Neurol, 30: 37-41, 2017
60. Singu T, Inatomi Y, Yonehara T, Ando Y:
Calcified amorphous tumor causing shower embolism to the brain: A case report with serial echocardiographic and neuroradiologic images and a review of the literature.
J Stroke Cerebrovasc Dis, 26: e85-e89, 2017
61. Inatomi Y, Nakajima M, Yonehara T, Ando Y:
Clinical characteristics of patients seizure following the 2016 Kumamoto earthquake.
J Clin Neurosci, 40: 123-129, 2017
62. Hayashi Y, Higashi T, Motoyama K, Jono H, Ando Y, Arima H:
In vitro and in vivo siRNA delivery to hepatocyte utilizing ternary complexation of lactosylated dendrimer/cyclodextrin conjugates, siRNA and low-molecular-weight sacran.
Int J Biol Macromol, 107: 1113-1121, 2018
63. Fukasawa K, Higashimoto Y, Ando Y, Motomiya Y:
Selection of DNA aptamer that blocks the fibrillogenesis of a proteolytic amyloidogenic fragment of β2 m.
Ther Apher Dial, 22: 61-66, 2018
64. Inatomi Y, Nakajima M, Yonehara T, Ando Y:
Clinical characteristics of patients with ischemic stroke following the 2016 Kumamoto earthquake.
J Clin Neurosci, 46: 79-84, 2018
65. Ikenoshita S, Yamashita S, Sakamoto T, Misumi Y, Ando Y:
Hemiatrophy of the tongue with contralateral hemiparesis in a patient with multifocal acquired demyelinating sensory and motor neuropathy.
J Clin Neurol, 13: 422-423, 2017
66. Singu T, Inatomi Y, Yonehara T, Ando Y:
Delayed leukoencephalopathy after recanalized cardioembolic stroke: Two case reports.
J Neurol Sci, 379: 81-83, 2017
67. Nishi S, Hoshino J, Yamamoto S, Goto S, Fuji H, Ubara Y, Motomiya Y, Morita H, Takaichi K, Yamagata K, Shigematsu T, Ueda M, Ando Y:
A multicenter cross sectional study for bone-articular lesions associated with dialysis related amyloidosis in Japan.
Nephrology, 23: 640-645, 2018
68. Ando Y, Ueda M:
Antibody therapy for transthyretin-related hereditary amyloid polyneuropathy: another therapeutic option.
Amyloid, 24: 113-114, 2017
69. Tsuda N, Shiraishi S, Oda S, Ogasawara K, Sakamoto F, Tomiguchi S, Fujisue K, Takashio S, Izumiya Y, Tsujita K, Ando Y, Yamashita Y:
Utility of single-photon emission computed tomography/computed tomography fusion imaging with 99 mTc-Pyrophosphate scintigraphy in the assessment of cardiac transthyretin amyloidosis.
Circ J, 82: 1970-1971, 2018
70. Oda S, Nakaura T, Utsunomiya D, Hirakawa K, Takashio S, Izumiya Y, Tsujita K, Hata H, Ando Y, Yamashita Y:
Late iodine enhancement and myocardial extracellular volume quantification in cardiac amyloidosis by using dual-energy cardiac computed tomography performed on a dual-layer spectral detector scanner.
Amyloid, 25: 137-138, 2018
71. Ikeda T, Masuda T, Ueda M, Yamashita T, Misumi Y, Shinriki S, Ando Y:
Unwanted road to anaemia in transthyretin familial amyloid polyneuropathy may continue irrespective of tafamidis treatment.
Ann Clin Biochem, 55: 571-575, 2018
72. Mukaino A, Nagaoka A, Yoshimura S, Nakajima H Shiraishi H, Motomura M, Morikawa M, Kusunoki S, Nakane S, Ando Y, Tsujino A:
Modified method of intravenous immunoglobulin administration for patients with intractable multifocal motor neuropathy: A case report.
Clinical and Experimental Neuroimmunology, 2: 141-145, 2017
